European Society of Cardiology
Skip navigation links
About the ESC
Guidelines & Surveys
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe

Hot Line, Clinical Trial Update and Registry Sessions

ESC Congress 2013

Discover some of the most anticipated science and clinical innovation of the year.
Not only that but a new presentation format which allows for questioning and debate will guarantee that you really are at the sharp end of cardiovascular science.

Hot Line sessions

NEW ! More discussions & opinions on the latest findings presented.
Each Hot Line presentations will be followed by a discussant review which will launch discussions with the panel of experts and the audience on the latest findings presented.
These sessions will be held in Room Amsterdam (Central Village).

Sunday 1 September
11:00 - 12:30 Hot Line I: Late Breaking Trials on Thrombosis 
14:00 - 15:30  Hot Line II: Late Breaking Trials on Intervention and devices 

Monday 2 September
11:00 - 12:30 Hot Line III: Late Breaking Trials on Risk factors and Diabetes 

Tuesday 3 September
11:00 - 12:30 Hot Line IV: Late Breaking Trials on Heart Failure and Acute Coronary Syndrome  

Clinical Trial Updates Hot Lines

NEW ! More discussions & exchange on the Clinical Trials
Clinical Trial presentations will be followed by a brief discussant editorial to launch discussions with the panel of experts.

Monday 2 September
14:00 - 15:30  Clinical Trial Update Hot Line I: Updates on hypertension, heart failure and diabetes - Room Amsterdam (Central Village)

Tuesday 3 September
11:00 - 12:30  Clinical Trial Update Hot Line  II: Updates on intervention and devices - Room Skopje (Village 5)
Wednesday 4 September
08:30 - 10:00  Clinical Trial Update Hot Line III: Updates on risk and outcome - Room Amsterdam (Central Village)


Registry Hot Line

NEW – Fast Paced presentation of the key elements of the registries followed by one-to-one discussions.

The registry presenters will have 5 minutes to present and ample time for with continued discussions on plasma screens around the room for the last part of the session, moderated and animated by chairpersons.

Sessions take place in  The Hub (Baku) Central Village - an area designed for interactive sessions.

Tuesday 3 September
13:00 - 14:15  Registries on risks, therapies and outcomes - 14:30 - 15:45 Registries on prevention and treatment  

Also - Don' t miss on Tuesday 3 September
11:00 - 12:30 The cardiovascular scenario in Europe: the ESC EurObservational Research Programme - Room Chisinau (Central Village)
A session dedicated to ESC registries including the ongoing registries and their present results conducted in the context of the EurObservational Research Programme (EORP) by the ESC and its Constituent Bodies.
The first large scale results of the ongoing ESC registries and the designs of the forthcoming observational studies.


Basic and Translational Science Hot Line

These sessions will present the latest and “hottest” findings of studies in basic and translational cardiovascular science; including cellular, molecular and genetic research and functional studies in genetically engineered mice and larger mammals.
Fast-Paced Presentations followed by discussions around plasma screens.
Sessions take place in  The Hub (Baku) Central Village - an area designed for interactive sessions.

Sunday 1 September
08:30 - 10:00  Basic and Translational Science Hot Line I – Vascular research -
Monday 2 September
12:45 - 14:00 Basic and Translational Science Hot Line II – Cardiac research -  

Meet the Trialists

Your chance to interact directly with six Late Breaking Trial presenters!

Sunday 1 September

15:40-16:20 Treatment of venous thromboembolism, the Hokusai VTE study - Room Damascus (Central Village)

15:40-16:20 TASTE: Thrombus aspiration during ST-segment elevation myocardial infarction. A multicenter, prospective, registry based randomized clinical trial - Room Tunis (The Hub-Central Village)

Monday 2 September

10:10-10:50 TAO: Otamixaban in non-ST-segment elevation acute coronary syndrome patients undergoing a planned invasive strategy - Room Damascus (Central Village)

15:40-16:20 PURE: Contrasting associations between risk factor burden, CVD incidence and mortality in high, middle and low income countries - The PURE sodium study: Sodium Heterogeneity in the associations of urinary sodium and potassium with blood pressure - Room Damascus (Central Village)

Tuesday 3 September

10:10-10:50 PRAMI: Preventive Angioplasty in Myocardial Infarction Trial - Room Damascus (Central Village)

10:10-10:50 SAVOR-TIMI 53 Study: Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus - Room Tunis (The Hub-Central Village)